North America Ablation Technologies Market

North America Ablation Technologies Market Size (2022 to 2027)

The size of the North America Ablation Technologies Market is valued at USD 1512.81 Million in 2022. This value is projected to reach USD 2595.44 Million by 2027, growing at a CAGR of 11.4% during the forecast period. North America is the biggest market in terms of market share across the globe. The U.S. holds a significant share of contribution due to a more extensive consumer base, healthcare services availability, and a higher adoption rate of these technologies.

Y-O-Y growth in the CVS diseases and rising occurrence rate of cancer in North American countries are significantly hiking the market growth in North America. Furthermore, increasing demand for minimally invasive surgical procedures and growing chronic disease incidence is predicted to boost the North American market. According to the National Library of Medicine, an estimated 12.1 million in the United States to suffer from atrial fibrillation by 2030.

Continuous healthcare reforms in the U.S. and reutilization and regenerating of devices among the developing countries are expected to hamper the market's growth rate to a small extent from 2020 to 2025. Strict regulations for the ablation devices' acceptance and the ablation devices' cost are likely to restrain the market growth.

This research report on the North America Ablation Technologies Market has been segmented and sub-segmented into the following categories:

• By Product: Light/Laser ablators, Radiofrequency (RF) ablators, Electrical ablators, Ultrasound ablators, Microwave ablators, Cryoablation devices, Hydrothermal ablators.
• By Type: Light/Laser Ablation, Radiofrequency Ablation, Electrical Ablation, Ultrasound Ablation, Cryoablation, Microwave Ablation, Hydrothermal Ablation.
• By Application: Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmologic Treatment, Gynecologic Treatment, Pain Management, Urologic Treatment, Orthopedic Treatment, Cosmetic Surgery, Other Treatments.
• By Country: US, Canada & Rest of North America.

Based on the region, The United States market is predicted to occupy most of the market share in the North American market during the forecast period. An increasing number of product launches of the ablation systems and increasing amount spent on enhancing the healthcare infrastructure and obtainment of cardiac ablation technologies are expected to support the United States market. The cancer prevalence in the United States is growing significantly. An estimated 1,735,350 new cancer cases are diagnosed, and 609,640 deaths occurred due to cancer in the United States, as per American Cancer Society, published in 2018.

Canada’s contribution will also rise due to the adoption of new ablation technologies such as microwave and radiation. Increasing the acquisition of novel ablation technologies like microwaves and radiation, which propel the market. The rising old people population, research, and development of most efficient and ultra-modern ablation technologies help accelerate market growth during the analysis period. Two hundred twenty thousand four hundred new cancer cases were diagnosed in Canada in 2019, and 2 Canadians 1 is diagnosed with cancer in their lifetime. The number of cancer cases in males is 113,000, which is higher than in females with 107,400.

Promising Companies leading the North America Ablation Technologies Market Profiled in the Report are Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., BSD Medical Corporation, are the significant players of North America Ablation Technologies market.